Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
PRNewswire - December 29, 2006
LOS ANGELES, Dec. 29 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the US' largest provider of HIV/AIDS healthcare, education and prevention and operator of free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, today called on the pharmaceutical industry to immediately mobilize and work together to donate lifesaving HIV/AIDS drugs and/or money to eliminate waiting lists on several of the federally-funded, state-run AIDS Drug Assistance Programs (ADAP) nationwide. State ADAPs are funded by the federal Ryan White CARE Act and are the primary source of HIV/AIDS medications for uninsured and underinsured Americans. The call to the drug industry from AHF was renewed after the 'New York Times' reported that four people in South Carolina had died -- and 350 people with HIV/AIDS remain -- on a waiting list to receive lifesaving AIDS medications through the state's ADAP.
"It is simply unacceptable for someone in this country to die from AIDS because of lack of access to lifesaving medications that may be sitting -- unused -- in a drug company warehouse nearby," said Michael Weinstein, President of AIDS Healthcare Foundation. "Why weren't these South Carolina patients -- or all of the patients on ADAP waiting lists around the country -- being offered medications through drug companies' Patient Assistance Programs? Given the enormous profit that pharmaceutical companies reap by selling medications to government programs -- by far the largest purchasers of drugs in this country -- it is incumbent upon these companies to cover such needy low-income AIDS patients who are not able to access these medications due to state and federal funding gaps. AHF is calling on the pharmaceutical industry to do more to ensure that such AIDS patients in need have access to treatments. We are also demanding that the pharmaceutical industry pick up the tab for all of these wait-listed ADAP patients, and that as a requirement for participating in, and placing its drugs on ADAP formularies in the future, that the industry itself institute a streamlined, collaborative and common-sense program of drug and/or monetary donations that ensures that waiting lists become a thing of the past."
According to the 'New York Times' article ("Waiting List for AIDS Drugs Causes Dismay in South Carolina," Dewan, 12/29/06), "State officials say it would cost South Carolina $3 million to clear the waiting list. The only other state with such a list right now, Alaska, has 13 people waiting. The number of states with waiting lists fluctuates."
"Even if HIV positive individuals in South Carolina have access to medical care and CD4 monitoring, without access to antiretroviral treatment, many will progress to an AIDS-defining illness over time," said Charles Farthing, MD, Chief of Medicine for AIDS Healthcare Foundation. "This is unfortunate, as the AIDS drug therapies we have today can truly enable people to live normal, healthy lives. We must find some way to make sure that those in need of these lifesaving treatments have access to them."
State funding cuts in South Carolina originally led to the creation of the waiting list, which started in June.
SOURCE AIDS Healthcare Foundation
061229
PR061245
Copyright © 2006 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .